VAERS Explorer
Back to explore

Report #2869270

Received Oct 29, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Male
Age
Age unknown
State
WI
Recovered
Unknown
Vaccinated
Oct 17, 2025
Onset
Oct 17, 2025
Days to onset
0
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
DTAPHEPBIPDTAP + HEPB + IPV (PEDIARIX)GLAXOSMITHKLINE BIOLOGICALSUNKTC47K—

Symptoms (1)

Product administered to patient of inappropriate age

Symptom narrative

dose of Pediarix was given to a 13-year-old patient; This non-serious case was reported by a nurse via call center representative and described the occurrence of inappropriate age at vaccine administration in a 13-year-old male patient who received DTPa-HBV-IPV (Pediarix) (batch number TC47K, expiry date 29-MAR-2026) for prophylaxis. On 17-OCT-2025, the patient received Pediarix. On 17-OCT-2025, an unknown time after receiving Pediarix, the patient experienced inappropriate age at vaccine administration (Verbatim: dose of Pediarix was given to a 13-year-old patient). The outcome of the inappropriate age at vaccine administration was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.